Kaken Pharmaceuticals

Japan

Kaken Pharmaceuticals is a pharmaceutical company based in Japan that focuses on the development, manufacturing, and commercialization of various drugs, including those for pain relief and anti-inflammatory treatments.

CCI Score

26.16

-0.02% April 18

Latest Event

Licensing Agreement Collaboration with Alumis Inc

On March 25, 2025, Alumis Inc announced a collaboration and licensing agreement with Kaken Pharmaceuticals. Under this agreement, Alumis is licensing the drug candidate ESK-001 to Kaken for development, manufacturing, and commercialization in Japan, specifically for dermatologic applications.

Take Action

So what can you do? Support Kaken by shopping, spreading the word, or offering your support.

Shop Alternatives SEE ALL: Almirall

Novo Nordisk

Bausch Health
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

DISSENTER

Kaken Pharmaceuticals is currently rated as a Dissenter.

+25 to +44 CCI Score

These companies are vocal in their opposition to authoritarian regimes. They publicly criticize oppressive policies and engage in advocacy efforts to promote accountability and transparency, even if their actions aren’t as extensive as those of Moral Leaders.

Latest Events

MAR

25

2025

Licensing Agreement Collaboration with Alumis Inc
20.00

On March 25, 2025, Alumis Inc announced a collaboration and licensing agreement with Kaken Pharmaceuticals. Under this agreement, Alumis is licensing the drug candidate ESK-001 to Kaken for development, manufacturing, and commercialization in Japan, specifically for dermatologic applications.
OCT

01

2023

Enhanced Corporate Governance and Transparency
32.31

Kaken Pharmaceuticals outlines a robust corporate governance framework that emphasizes high ethical standards, transparency, and accountability through its board structure, including outside directors and regular meetings. The company's approach, framed around the 'Three Joys' philosophy, underscores its commitment to societal trust and responsible management.
+40

Public and Political Behavior

April 7

The disclosed corporate governance structure, including the active participation of outside directors and regular board meetings, enhances transparency and accountability. This practice supports public trust and reduces the risk of centralized, authoritarian decision-making.

Corporate Governance - KAKEN PHARMACEUTICAL CO., LTD.
+35

Business Practices and Ethical Responsibility

April 7

Kaken Pharmaceuticals’ governance practices, which emphasize ethical operations and clear accountability, reflect a strong commitment to business ethics. This approach helps prevent the misuse of corporate power and supports a healthy, democratic business environment.

Corporate Governance - KAKEN PHARMACEUTICAL CO., LTD.